Focal Segmental Glomerulosclerosis - 27 Studies Found

Terminated : Safety and Pharmacokinetics of FG-3019 in Adolescents and Adults With Focal Segmental Glomerulosclerosis (FSGS)
: Focal Segmental Glomerulosclerosis
: 2008-10-27
: Drug: FG-3019 FG-3019 5 mg/kg IV given over 2 hours every 2 weeks for 8 weeks
Terminated : Therapeutic Effect of Low-dose Prednisone Combined With MMF and FK506 in Focal Segmental Glomerulosclerosis
: Focal Segmental Glomerulosclerosis
: 2009-08-10
:
  • Drug: prednisone, FK506, MMF 1
Completed : Permeability Factor in Focal Segmental Glomerulosclerosis
: Focal Segmental Glomerulosclerosis
: 2000-12-22
:
  • Procedure: Plasma exchange A c
Terminated : Effect of Oral Galactose on Focal Segmental Glomerulosclerosis (FSGS) Permeability Factor
: Focal Segmental Glomerulosclerosis
: 2008-12-31
: Drug: Galactose Oral galactose, 0.2 g/kg/dose twice daily for 28 days
Completed : Allogenic AD-MSC Transplantation in Idiopathic Nephrotic Syndrome (Focal Segmental Glomerulosclerosis)
: Focal Segmental Glomerulosclerosis
: 2015-03-03
: Biological: Intravenous injection Intravenous injection of AD-MSC to the patients with FSGS
Active, not recruiting : Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis
: Focal Segmental Glomerulosclerosis
: 2012-06-04
:
  • Drug: RE-021 (Sparsentan) Oral
Completed : Safety Study of GC1008 in Patients With Focal Segmental Glomerulosclerosis (FSGS) of Single Doses of GC1008 in Patients With Treatment Resistant Idiopathic FSGS
: Focal Segmental Glomerulosclerosis
: 2007-04-20
:
  • Biological: GC1008 1 mg/kg, IV
Completed : Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT)
: Glomerulosclerosis, Focal
: 2005-08-24
:
  • Drug: Cyclosporin Participants
Completed : Rituximab Treatment of Focal Segmental Glomerulosclerosis
: Focal Segmental Glomerulosclerosis (FSGS)
: 2007-10-26
: Drug: rituximab 375 mg/m2 intravenously for 4 doses
Completed : Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
: Focal Segmental Glomerulosclerosis 1
: 2014-09-06
: Device: Liposorber® LA-15 System Liposorber® LA-15 System is an extracorporeal blood purificat
Next >>>